美国癌症协会2018年一般风险成人结直肠癌筛查指南更新
美国癌症协会基于系统证据综述和微模拟建模分析更新一般风险成人结直肠癌筛查指南,推荐45岁及以上一般风险成人定期筛查,可选高灵敏度粪便检测或结构(视觉)检查,非结肠镜筛查阳性者应及时结肠镜检查。
要点
- 45岁及以上一般风险成人应定期筛查,可选高灵敏度粪便检测或结构检查。
- 非结肠镜筛查阳性结果应随访及时结肠镜检查。
- 50岁及以上成人定期筛查为强推荐,45岁开始筛查为有条件推荐。
核心结论
- ACS推荐45岁及以上一般风险成人定期结直肠癌筛查,可选高灵敏度粪便检测或结构(视觉)检查,取决于患者偏好和检测可及性。
研究设计与样本
- ACS指南制定组基于现有结直肠癌筛查文献系统证据综述和微模拟建模分析,包括按种族和性别评估筛查起始年龄及纳入美国结直肠癌发病率变化的额外建模。
主要发现
- 建模分析识别出从45岁开始筛查的高效且模型可推荐策略。
- 任一筛查选项通过检出和切除腺瘤性息肉及其他癌前病变与结直肠癌发病率显著降低相关,并通过发病率降低和早期检出与死亡率降低相关。
关键数值与推荐
- ACS推荐45岁及以上一般风险成人定期筛查,45岁开始筛查为有条件推荐。
- 50岁及以上成人定期筛查为强推荐。
- 健康状况良好且预期寿命超过10年的一般风险成人继续筛查至75岁(有条件推荐)。
- 76至85岁个体根据患者偏好、预期寿命、健康状况和既往筛查史个体化决策(有条件推荐)。
- 超过85岁个体不建议继续筛查(有条件推荐)。
临床怎么用
- 临床医生应与45岁及以上一般风险成人讨论筛查选项,根据患者偏好和检测可及性选择高灵敏度粪便检测或结构检查。
- 非结肠镜筛查阳性结果应及时转诊结肠镜检查。
- 对76至85岁个体应结合偏好、预期寿命、健康状况和既往筛查史个体化决策,超过85岁不建议继续筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model-recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average-risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high-sensitivity, guaiac-based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250-281. © 2018 American Cancer Society.
引用
- Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018. PMID: 29846947. doi:10.3322/caac.21457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。